FIELD: chemistry.
SUBSTANCE: invention refers to pharmaceutical chemistry and discloses two crystalline forms of hidamide, in particular, crystalline form A of hidamide and crystalline form B of hidamide, as well as a method of producing crystalline forms A and B of hidamide, use thereof and a pharmaceutical composition based thereon.
EFFECT: technical result is obtaining crystalline forms A and B of hidamide, which have low toxicity, stability during storage and processing, and also have the advantage in oral use and inhibiting the cell differentiation and proliferation.
7 cl, 8 dwg, 8 ex
Authors
Dates
2016-11-20—Published
2012-12-18—Filed